A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinib (Q82905603)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Kazuyuki Numakura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Norihiko Tsuchiya

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Takeshi Yuasa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mitsuru Saito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Takashi Obara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hiroshi Tsuruta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shintaro Narita

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yohei Horikawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shigeru Satoh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tomonori Habuchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

15 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

577-580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10147-010-0154-6

18 January 2020

exact match

0 references

cites work

Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion

1 reference

12 December 2020

Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells

1 reference

12 December 2020

TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition

1 reference

12 December 2020

Response to sunitinib malate in advanced alveolar soft part sarcoma

1 reference

12 December 2020

A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib

1 reference

12 December 2020

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents

1 reference

12 December 2020

Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network

1 reference

12 December 2020

Sunitinib: from rational design to clinical efficacy

1 reference

12 December 2020

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

1 reference

12 December 2020

Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma

1 reference

12 December 2020

SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells

1 reference

12 December 2020

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

1 reference

12 December 2020

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

10.1007/S10147-010-0154-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161315%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference